Title Search [BP SY 3-1] Surveillence strategy based on the natural course of IPMN: How often and until when? Wooil KWON (Seoul National University, Korea) [BP SY 3-2] What is new in revised guidelines: Indications and timing of surgery Takao OHTSUKA (Kagoshima University, Japan) [BP SY 3-3] Adjuvant chemotherapy for resected invasive IPMN. Do we have evidence comparing with typical pancreatic cancer? Chang Moo KANG (Yonsei University, Korea) [BP SY 3-4] Recent updated biomarkers to predict malignant changes of IPMN Christopher WOLFGANG (NYU Langone Health, USA)